Development and Validation of a Novel Conditional Event‐Free Survival Tool in Diffuse Large B‐Cell Lymphoma

Overview of attention for article published in American Journal of Hematology, June 2026

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (79th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

news: 1 news outlet

twitter: 2 X users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 11,893 followers.

https://t.co/2541UDndAS #Technology #Science #Finance #Tech #digitalHealth #MEDtwitter my @enilev🪔mom #BOSCh #Pfizer #ecb

Excited to share that our paper on developing a novel conditional event-free survival (cEFS) tool in DLBCL has finally been published! https://t.co/tdFwAXozeZ

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.